318 related articles for article (PubMed ID: 25605481)
21. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
22. New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies.
Tsai CH; Chen YL; Pan CT; Lin YT; Lee PC; Chiu YW; Liao CW; Chen ZW; Chang CC; Chang YY; Hung CS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():646933. PubMed ID: 34108934
[TBL] [Abstract][Full Text] [Related]
23. Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism.
Ahmed S; Hundemer GL
Front Endocrinol (Lausanne); 2022; 13():861581. PubMed ID: 35557845
[TBL] [Abstract][Full Text] [Related]
24. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
25. Minimally Invasive Partial Versus Total Adrenalectomy for the Treatment of Primary Aldosteronism: Results of a Multicenter Series According to the PASO Criteria.
Anceschi U; Tuderti G; Fiori C; Zappalà O; Ferriero MC; Brassetti A; Carrara A; Tirone G; De Concilio B; Celia A; Porpiglia F; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1418-1423. PubMed ID: 32660839
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically.
Ahmed AH; Gordon RD; Sukor N; Pimenta E; Stowasser M
J Clin Endocrinol Metab; 2011 Sep; 96(9):2904-11. PubMed ID: 21778218
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure.
Yang Y; Reincke M; Williams TA
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):100-108. PubMed ID: 30130807
[TBL] [Abstract][Full Text] [Related]
28. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
29. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.
Worth PJ; Kunio NR; Siegfried I; Sheppard BC; Gilbert EW
Am J Surg; 2015 Oct; 210(4):702-9. PubMed ID: 26323999
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis.
Chen SY; Chen JY; Huang WC; Puar THK; Chin Kek P; Chueh JS; Lin YH; Wu VC; Study Group T
Eur J Endocrinol; 2022 Dec; 187(6):S47-S58. PubMed ID: 36315466
[TBL] [Abstract][Full Text] [Related]
31. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism.
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chung SD;
Endocrinol Metab (Seoul); 2020 Dec; 35(4):838-846. PubMed ID: 33261310
[TBL] [Abstract][Full Text] [Related]
32. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY
Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
[TBL] [Abstract][Full Text] [Related]
33. Outcome of surgical treatment of primary aldosteronism.
Citton M; Viel G; Rossi GP; Mantero F; Nitti D; Iacobone M
Langenbecks Arch Surg; 2015 Apr; 400(3):325-31. PubMed ID: 25567077
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of adrenalectomy in patients with primary hyperaldosteronism--a single centre experience.
Hartmann I; Grepl M; Vidlar A; Smakal O; Vaclavik J; Frysak Z; Dolezel M; Student V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):583-90. PubMed ID: 25471827
[TBL] [Abstract][Full Text] [Related]
35. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis.
Zhou Y; Zhang M; Ke S; Liu L
BMC Endocr Disord; 2017 Oct; 17(1):61. PubMed ID: 28974210
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
Horký K; Widimský J; Hradec E; Gregorová I; Hradec M
Exp Clin Endocrinol; 1987 Dec; 90(3):337-46. PubMed ID: 3450533
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
[TBL] [Abstract][Full Text] [Related]
38. Eplerenone use in primary aldosteronism during pregnancy.
Cabassi A; Rocco R; Berretta R; Regolisti G; Bacchi-Modena A
Hypertension; 2012 Feb; 59(2):e18-9. PubMed ID: 22146514
[No Abstract] [Full Text] [Related]
39. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
Fourkiotis V; Vonend O; Diederich S; Fischer E; Lang K; Endres S; Beuschlein F; Willenberg HS; Rump LC; Allolio B; Reincke M; Quinkler M;
Eur J Endocrinol; 2013 Jan; 168(1):75-81. PubMed ID: 23033260
[TBL] [Abstract][Full Text] [Related]
40. Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Watanabe M; Kamemura K; Okamura S; Tanabe A; Naruse M;
Sci Rep; 2021 Mar; 11(1):6925. PubMed ID: 33767283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
